Dow Up 0.15% Nasdaq Up 0.15%

More On IMU.AX

Quotes

Charts

News & Info

Company

Analyst Coverage

  • Analyst Opinion
  • Analyst Estimates

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials

Imugene Ltd. (IMU.AX)

-ASX
0.02 Up 0.00(6.67%) 1:58AM EDT
Prev Close:0.02
Open:0.02
Bid:N/A
Ask:N/A
1y Target Est:N/A
Beta:N/A
Next Earnings Date:N/A
Day's Range:0.02 - 0.02
52wk Range:0.01 - 0.03
Volume:980,093
Avg Vol (3m):831,542
Market Cap:15.14M
P/E (ttm):N/A
EPS (ttm):-0.01
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in AUD.

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):26.38
Ex-Dividend Date:N/A

Analysts

Annual EPS Est () :N/A
Quarterly EPS Est () :N/A
Mean Recommendation*:N/A
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Imugene Limited, a pharmaceutical company, is engaged in the research, development, and commercialization of health technologies in Australia. The company’s drug delivery platform technology, Linguet enables the active ingredient of drugs to ... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback